305 related articles for article (PubMed ID: 29749834)
1. Enabling personalized medicine in Europe by the European Commission's funding activities.
Nimmesgern E; Norstedt I; Draghia-Akli R
Per Med; 2017 Jul; 14(4):355-365. PubMed ID: 29749834
[TBL] [Abstract][Full Text] [Related]
2. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
[TBL] [Abstract][Full Text] [Related]
3. Public funding for research on antibacterial resistance in the JPIAMR countries, the European Commission, and related European Union agencies: a systematic observational analysis.
Kelly R; Zoubiane G; Walsh D; Ward R; Goossens H
Lancet Infect Dis; 2016 Apr; 16(4):431-40. PubMed ID: 26708524
[TBL] [Abstract][Full Text] [Related]
4. Consensus document on European brain research.
Olesen J; Baker MG; Freund T; di Luca M; Mendlewicz J; Ragan I; Westphal M
J Neurol Neurosurg Psychiatry; 2006 Aug; 77 Suppl 1(Suppl 1):i1-49. PubMed ID: 16845120
[TBL] [Abstract][Full Text] [Related]
5. Enabling personalized medicine in Europe: a look at the European Commission's funding activities in the field of personalized medicine research.
Draghia-Akli R
Per Med; 2012 Mar; 9(2):151-155. PubMed ID: 29758818
[TBL] [Abstract][Full Text] [Related]
6. An overview of Personalized Medicine landscape and policies in the European Union.
Beccia F; Hoxhaj I; Castagna C; Strohäker T; Cadeddu C; Ricciardi W; Boccia S
Eur J Public Health; 2022 Nov; 32(6):844-851. PubMed ID: 36305782
[TBL] [Abstract][Full Text] [Related]
7. Europe's 'Horizon 2020' science funding programme: how is it shaping up?
Galsworthy M; McKee M
J Health Serv Res Policy; 2013 Jul; 18(3):182-5. PubMed ID: 23595575
[TBL] [Abstract][Full Text] [Related]
8. European healthcare systems readiness to shift from 'one-size fits all' to personalized medicine.
Schee Genannt Halfmann S; Evangelatos N; Schröder-Bäck P; Brand A
Per Med; 2017 Jan; 14(1):63-74. PubMed ID: 29749826
[TBL] [Abstract][Full Text] [Related]
9. Horizon 2020 SME-Instrument topic: clinical research for the validation of biomarkers and/or diagnostic medical devices.
Sanne JL
Per Med; 2018 Jul; 15(4):303-309. PubMed ID: 29927355
[TBL] [Abstract][Full Text] [Related]
10. New indicators and indexes for benchmarking university-industry-government innovation in medical and life science clusters: results from the European FP7 Regions of Knowledge HealthTIES project.
Edmunds LD; Gluderer S; Ovseiko PV; Kamerling R; Ton J; Vis L; Jenni M; Tutton G; Lawton-Smith H; Nadabán MV; Rab M; Rees J; Anson J; Rushforth AD; Allen M; Buchan AM; Vendrell M; Casta A; Mehes G; Hogendoorn PCW; Hafen E; Hassan AB
Health Res Policy Syst; 2019 Jan; 17(1):10. PubMed ID: 30691504
[TBL] [Abstract][Full Text] [Related]
11. Horizon Europe, research and innovation programme until 2027 - what is new comparing with Horizon 2020?
Kinkorová J
Cas Lek Cesk; 2022; 161(3-4):163-166. PubMed ID: 36100458
[TBL] [Abstract][Full Text] [Related]
12. Drug delivery research in the European Union's Seventh Framework Programme for Research.
Frima HJ; Gabellieri C; Nilsson MI
J Control Release; 2012 Jul; 161(2):409-15. PubMed ID: 22333557
[TBL] [Abstract][Full Text] [Related]
13. Mapping the European cancer research landscape: An evidence base for national and Pan-European research and funding.
Begum M; Lewison G; Lawler M; Sullivan R
Eur J Cancer; 2018 Sep; 100():75-84. PubMed ID: 30014883
[TBL] [Abstract][Full Text] [Related]
14. "Integrating China in the International Consortium for Personalized Medicine": The Coordination and Support Action to Foster Collaboration in Personalized Medicine Development between Europe and China.
Morsella A; Cadeddu C; Castagna C; Hoxhaj I; Sassano M; Wang CM; Wang L; Klessova S; de Belvis AG; Boccia S; Ricciardi W
Public Health Genomics; 2021; 24(5-6):310-314. PubMed ID: 34392247
[TBL] [Abstract][Full Text] [Related]
15. A survey of experts on personalized medicine landscape in European Union and China.
Hoxhaj I; Beccia F; Morsella A; Cadeddu C; Ricciardi W; Boccia S
BMC Health Serv Res; 2023 May; 23(1):517. PubMed ID: 37221524
[TBL] [Abstract][Full Text] [Related]
16. Sino-European science and technology collaboration on personalized medicine: overview, trends and future perspectives.
Romagnuolo I; Mariut C; Mazzoni A; Santis G; Moltzen E; Ballensiefen W; Lange C; Frosini A; D'Errico G
Per Med; 2021 Sep; 18(5):455-470. PubMed ID: 34060340
[No Abstract] [Full Text] [Related]
17. European Union vaccine research--an overview.
Sautter J; Olesen OF; Bray J; Draghia-Akli R
Vaccine; 2011 Sep; 29(39):6723-7. PubMed ID: 21195799
[TBL] [Abstract][Full Text] [Related]
18. [Establishing ophthalmology in the research framework programs of the European Union].
Scholl HP; Wheeler-Schilling TH; Zrenner E; Holz FG
Ophthalmologe; 2006 Feb; 103(2):91-9. PubMed ID: 16437232
[TBL] [Abstract][Full Text] [Related]
19. European Union investment and countries' involvement in mental health research between 2007 and 2013.
Hazo JB; Gervaix J; Gandré C; Brunn M; Leboyer M; Chevreul K
Acta Psychiatr Scand; 2016 Aug; 134(2):138-49. PubMed ID: 27145870
[TBL] [Abstract][Full Text] [Related]
20. Coverage With Evidence Development and Managed Entry in the Funding of Personalized Medicine: Practical and Ethical Challenges for Oncology.
Lewis JR; Kerridge I; Lipworth W
J Clin Oncol; 2015 Dec; 33(34):4112-7. PubMed ID: 26460298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
